- Report
- February 2024
- 114 Pages
Global
From €4250EUR$4,750USD£3,635GBP
- Report
- April 2023
- 115 Pages
Global
From €4250EUR$4,750USD£3,635GBP
- Report
- April 2023
- 117 Pages
Global
From €4250EUR$4,750USD£3,635GBP
- Report
- April 2023
- 120 Pages
Global
From €4250EUR$4,750USD£3,635GBP
- Report
- April 2023
- 112 Pages
Global
From €4250EUR$4,750USD£3,635GBP
- Report
- June 2025
- 172 Pages
Global
From €4026EUR$4,500USD£3,443GBP
- Report
- July 2025
- 250 Pages
North America
From €3462EUR$3,869USD£2,960GBP
- Report
- June 2025
- 400 Pages
Global
From €4428EUR$4,949USD£3,787GBP
- Report
- June 2025
- 400 Pages
Global
From €4428EUR$4,949USD£3,787GBP
- Report
- June 2025
- 400 Pages
Global
From €4428EUR$4,949USD£3,787GBP
- Report
- June 2025
- 250 Pages
India
From €2495EUR$2,789USD£2,134GBP
- Report
- August 2024
- 200 Pages
Global
From €4428EUR$4,949USD£3,787GBP
- Report
- July 2024
- 200 Pages
Global
From €4428EUR$4,949USD£3,787GBP
- Report
- August 2025
- 154 Pages
Global
From €3534EUR$3,950USD£3,022GBP
- Report
- January 2024
- 143 Pages
Global
From €3803EUR$4,250USD£3,252GBP
- Report
- May 2026
- 90 Pages
China
From €2550EUR$2,850USD£2,181GBP
- Report
- June 2025
- 141 Pages
Global
From €3534EUR$3,950USD£3,022GBP
- Report
- May 2026
- 201 Pages
Netherlands
From €4340EUR$4,850USD£3,711GBP
- Report
- May 2026
- 162 Pages
China
From €4340EUR$4,850USD£3,711GBP
- Report
- May 2026
- 164 Pages
South Africa
From €4340EUR$4,850USD£3,711GBP
Personalized Medicine in Oncology is a field of medicine that uses genomic information to tailor treatments to individual patients. This approach is based on the idea that each patient's cancer is unique and requires a personalized approach to treatment. Genomics is used to identify the genetic mutations that are driving the cancer, and then treatments are tailored to target those mutations. This approach has the potential to improve outcomes and reduce side effects, as treatments are more targeted and tailored to the individual patient.
Companies in the Personalized Medicine in Oncology market include Illumina, Thermo Fisher Scientific, QIAGEN, Agilent Technologies, and PerkinElmer. Show Less Read more
